Optin Pharma Private Limited
About Optin Pharma Private Limited
Data last updated:
Optin Pharma Private Limited is a private limited company based in Uppal, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 12 May 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21002TS2023PTC173003.
The company has an authorised share capital of ₹2.65 Cr and a paid-up capital of ₹2.65 Cr. It is led by directors Rajesh Mukkera (Managing Director) and Babu Mukkera.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Uppal, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.01 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹82.72 Lakh (net margin -223.5%) and EBITDA of -₹73.97 Lakh (EBITDA margin -199.9%).
As per MCA filings, the company has open charges of ₹1.1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 13 Phase 11, Cherlapally, Uppal, Telangana, India – 500051
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Optin Pharma Private Limited FY 2025 filings available
Optin Pharma Private Limited reported revenue of ₹37.01 Lakh (up 770983% YoY) for FY 2025.
Financial Statement Summary of Optin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹73.97 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹82.72 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Optin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -199.9% | •••• |
| Net Profit Margin | -223.5% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Optin Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Optin Pharma Private Limited
Optin Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hyderabad Laboratories Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Forward Life Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Total Herb Solutions Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Bioviser Pharma Consulting Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Shruutas Pharmaceutical Private Limited | •••• | •••• | •••• | •••• | - | Thane, Maharashtra, India |
| Optin Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Uppal, Telangana, India |
| Amneal Biopharma Solutions Private Limited | •••• | •••• | •••• | •••• | - | Ahmadabad City, Gujarat, India |
| Simova India Lifesciences Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Prasad Idea Labs Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Anamle Design Solutions Private Limited | •••• | •••• | •••• | •••• | - | Balasore, Orissa, India |
| Pristine Pharma (India) Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Optin Pharma by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Board of Directors of Optin Pharma Private Limited
Optin Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Mukkera | Managing Director | 12 May 2023 | 3 Years 4 Months | Current |
| Babu Mukkera | Director | 12 May 2023 | 3 Years 4 Months | Current |
Charges & Borrowings of Optin Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2023 | Bank of India | ₹1.1 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Optin Pharma Private Limited
Employment history and EPFO contributions of people linked to Optin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Optin Pharma Private Limited
Optin Pharma Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Rajesh Mukkera ceased to be Director on 05 Nov 2023.
Credit Ratings, Litigation & Regulatory Alerts for Optin Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Optin Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Optin Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Optin Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Optin Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optin Pharma Private Limited
Optin Pharma is an active private limited company based in Uppal, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 12 May 2023 (3+ years old) and is registered under CIN U21002TS2023PTC173003.
Optin Pharma reported revenue of ₹37.01 Lakh for FY 2025 (up 770983% YoY).
Optin Pharma has 2 current directors:
- Rajesh Mukkera - Managing Director
- Babu Mukkera - Director
Optin Pharma reported a net loss of ₹82.72 Lakh (net margin -223.5%) and EBITDA of -₹73.97 Lakh (EBITDA margin -199.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Optin Pharma is U21002TS2023PTC173003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Optin Pharma was incorporated on 12 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Optin Pharma by revenue are Hyderabad Laboratories Private Limited, Forward Life Private Limited, Total Herb Solutions Private Limited, Bioviser Pharma Consulting Private Limited, Shruutas Pharmaceutical Private Limited and 5 more, all in the Pharma industry (Contract Research).
Rajesh Mukkera ceased to be Director on 05 Nov 2023. Babu Mukkera was appointed as Director on 12 May 2023. Rajesh Mukkera was appointed as Managing Director on 12 May 2023.
The registered office of Optin Pharma is at Plot No. 13 Phase 11, Cherlapally, Uppal, Telangana, India – 500051.
Optin Pharma has an authorised share capital of ₹2.65 Cr and a paid-up capital of ₹2.65 Cr.
Optin Pharma operates in the pharma industry, in the pharma contract r and d segment.